BerandaSDGR • NASDAQ
add
Schrodinger Inc
Tutup sebelumnya
$19,29
Rentang hari
$18,20 - $18,90
Rentang tahun
$16,67 - $33,63
Kapitalisasi pasar
1,38Â M USD
Volume Rata-Rata
587,35Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 35,29Â jt | -17,10% |
Biaya operasional | 86,15Â jt | 7,91% |
Laba bersih | -38,14Â jt | 38,51% |
Margin laba bersih | -108,06 | 25,83% |
Penghasilan per saham | -0,87 | -24,29% |
EBITDA | -66,86Â jt | -21,75% |
Tarif pajak efektif | 0,24% | — |
Neraca
Total aset
Total liabilitas
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 388,68Â jt | -21,68% |
Total aset | 669,30Â jt | -15,72% |
Total liabilitas | 219,87Â jt | -4,64% |
Total ekuitas | 449,42 jt | — |
Saham yang beredar | 72,86 jt | — |
Harga terhadap nilai buku | 3,13 | — |
Tingkat pengembalian aset | -25,20% | — |
Tingkat pengembalian modal | -29,30% | — |
Arus Kas
Perubahan kas bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -38,14Â jt | 38,51% |
Kas dari operasi | -33,26Â jt | 33,41% |
Kas dari investasi | 90,70Â jt | 587,00% |
Kas dari pembiayaan | 392,00Â rb | -70,53% |
Perubahan kas bersih | 57,84Â jt | 263,35% |
Arus kas bebas | -14,71Â jt | 61,72% |
Tentang
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
CEO
Didirikan
1990
Situs
Karyawan
867